Oxford, United Kingdom · Founded 2015 · Privately Held (backing)
Developer of an injectable bio-structural gel implant system designed to restore disc function and relieve back pain from degeneration. ORTHOSON is based in Oxford, United Kingdom and was founded in 2015. Its last reported valuation was $31 million in Oct 2025. It has raised $18.9 million.
Last reported valuation
$31.0M
Oct 2026
Priced at
—
Total raised
$18.9M
Last round
—
Cap table — not yet on record
ORTHOSON's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ORTHOSON with a free account
·The complete investor list: 12 names
·Watch ORTHOSON: the Monday email on marks, rounds and moves
